neil_weir_abpi-12

ABPI appoints new Innovation Board Chair

pharmafile | May 10, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Neil Weir, Whitehead 

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI Innovation Board. 

Weir was appointed to this position following the retirement of John Stageman in April of this year. 

Chief executive of the ABPI Stephen Whitehead, said: “With Neil’s introduction the ABPI is taking the opportunity to strengthen the link between our Innovation Board and our Board of Management. Supporting and encouraging innovation is the key role of our Innovation Board, but it is also a key consideration for the ABPI as a whole. 

“We’re very grateful to all the effort and hard work John Stageman put into the Innovation Board, and I’m confident that we have the right person in Neil to continue taking us forward.”

Advertisement

Commenting on his appointment Weir said: “I’m delighted to have been appointed Chair of the ABPI Innovation Board at such a critical time for our industry. As the shape of our industry continues to rapidly change our fate lies in the ability to continually innovate. Our ambition must be to offer innovative new medicines and ground-breaking solutions that go beyond the drug.

“We must remain committed to enabling cutting-edge scientific research that is driven by the patients’ needs but above all we should continue to focus on our core strength and offering, namely: innovation.”

The ABPI Innovation Board was set up to develop a long-term vision for pharmaceutical innovation in the UK.

Related Content

pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

brexit-hintergrund_web

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …

mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …

The Gateway to Local Adoption Series

Latest content